Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.


Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Wall Street Futures Slip as Tech Stocks Struggle Ahead of Key US Economic Data
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Oil Prices Rebound as Trump Orders Blockade of Sanctioned Venezuelan Tankers
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data
U.S. Dollar Slips Near Two-Month Low as Markets Await Key Jobs Data and Central Bank Decisions
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data
Biren Technology Targets Hong Kong IPO to Raise $300 Million Amid China’s AI Chip Push
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 



